Appendix B
Anatomical Therapeutic Chemical (ATC) codes used to identify cardiovascular-related medications

Warning View the most recent version.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.

Appendix B
Anatomical Therapeutic Chemical (ATC) codes used to identify cardiovascular-related medications
Table summary
This table displays the results of Anatomical Therapeutic Chemical (ATC) codes used to identify cardiovascular-related medications. The information is grouped by Medication (appearing as row headers), ATC code, ATC description and Excluding (appearing as column headers).
Medication ATC code ATC description Excluding
Anti-hypertensives C02
C03
C07
C08
C09
Miscellaneous anti-hypertensives
Thiazide diurectics
Beta-blockers
Calcium channel antagonists
Agents acting on the Renin-Angiotensin system
C02KX01
C03BA08, C03CA01
C07AA07, C07AA12, C07AG02
Lipid modifiers (statins) C10AA
C10AB
C10AC
C10AD
C10AX
C10BA
C10BX
HMG COA reductase inhibitors
Fibrates
Bile acid sequestrants
Nicotinic acid and derivatives
Other lipid modifying agents
HMG CoA reductase inhibitors in combination with other lipid-modifying agents
HMG CoA reductase inhibitors, other combinations
 
Anti-thrombotic agents (anti-coagulants) B01AA
B01AB
B01AE
B01AF
Vitamin K antagonists
Heparin group
Direct thrombin inhibitors
Direct factor Xa inhibitors
 
Anti-platelets B01AC Platelet aggregation inhibitors excluding heparin  
Report a problem on this page

Is something not working? Is there information outdated? Can't find what you're looking for?

Please contact us and let us know how we can help you.

Privacy notice

Date modified: